National Science Foundation
Breath-based Medical Diagnostics
Highlight ID 13545_html_me9b476e.jpg

Breath Gas Sampler

Permission Not Granted
State: Florida

Convergent Engineering, Inc. is developing signal processing algorithms and techniques for breath-based medical diagnostic applications. They have successfully developed data filters and signal processing algorithms that reduce sensor variability and have shown positive results in studies aimed at detecting propofol, a short-acting intravenous anesthetic agent, in the breath and blood of anesthetized animals.

The company is currently in the process of fabricating a prototype propofol monitoring device. This device is expected to be a significant improvement over current propofol monitoring methods and is targeted towards hospital-based anesthesiologists and surgeons, as well as office-based dentists, orthodontists and plastic surgeons.

Convergent Engineering, Inc is partnering with Biocatalyst for commercialization of its propofol monitoring device. Biocatalyst specializes in accelerating commercialization of science-based technologies. They expect a revenue stream starting in 2008. Much of Convergent Engineering’s success has been made possible by grants from the National Science Foundation and National Institutes of Health.

  Web Policies and Important Links | Privacy | FOIA | Help | Contact NSF | Contact Web Master | SiteMap